GleamWall
中文EN

BVS Bioventus Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1665988 · Fiscal year ends 12/31

Financial factors as of 2026-09-26 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.9%
TTM net income YoY655.0%
TTM EPS YoY575.0%
Revenue 3-yr CAGR5.2%
Net income 3-yr CAGR—

Margins

Gross margin68.7%
Operating margin9.7%
Net margin9.8%
FCF margin14.5%
EBITDA margin14.0%

Returns

ROE28.2%
ROA8.3%
ROIC (approx.)12.8%
Asset turnover0.85x

Leverage & solvency

Liabilities / assets56.7%
Debt / equity0.96x
Current ratio1.68x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.53x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$568.09M$573.28M
Cost of revenue$179.93M$185.05M
Gross profit$388.16M$388.23M
R&D expense$12.11M$13.95M
SG&A expense$314.03M$343.80M
Operating income$53.98M-$15.20M
Pretax income$25.71M-$52.34M
Income tax-$1.56M-$5.29M
Net income$22.73M-$36.12M
EBITDA$100.99M$34.36M
EPS (basic)0.34-0.56
EPS (diluted)0.33-0.56
Weighted avg. shares (diluted)68.91M64.55M
Balance sheet
Cash & equivalents$51.24M$41.58M
Receivables$128.30M$127.39M
Inventory$82.24M$92.47M
Current assets$272.84M$275.61M
PP&E, net$21.90M$27.01M
Goodwill$7.46M$7.46M
Intangibles$368.42M$404.73M
Total assets$683.56M$727.96M
Current liabilities$160.38M$210.40M
Short-term debt$15.00M$27.34M
Long-term debt$278.95M$308.29M
Total debt$293.95M$335.63M
Total liabilities$455.11M$542.35M
Shareholders' equity$184.10M$147.94M
Net debt$242.71M$294.05M
Cash flow statement
Operating cash flow$74.67M$38.80M
Capital expenditure$2.56M$1.01M
Free cash flow$72.11M$37.79M
Investing cash flow-$3.25M$22.96M
Financing cash flow-$62.14M-$54.58M
Depreciation & amortization$47.01M$49.55M
Stock-based compensation$12.67M$13.27M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.